Sitemap

Coronavirus Vaccine: EU Seals Deal With BioNTech, Pfizer

More...

Government Passes New Anti-coronavirus Measures

The Serbian government adopted new measures to...

US pharma firm Moderna says its COVID-19 vaccine is 94.5% effective

Moderna said that Phase 3 stage analysis...

US: Trump Fans Choose Parler Over Twitter

Since the social platforms Twitter and Facebook...

China Launches World’s First 6G Satellite Into Space To Test 6G Tech

China launches the world's first 6G satellite...

News

Diego Maradona: Argentina Legend Dies Aged 60

Football legend Diego Maradona, one of the greatest players of all time, has died at the age of 60. The...

Serbian Student Heads Second-Placed Team At Internet Innovation Competition

Mensa Serbia said on Tuesday that a Serbian doctoral candidate headed the team that won silver at the China...

EIB Supports Digitalisation Of Schools With €65 Million

Modern IT equipment and high-speed internet for primary and secondary schools across Serbia. 50 000 teachers to improve...

G20 Summit: G20 Leaders United To Address Major Global Pandemic And Economic Challenges

President of the European Commission, Ursula von der Leyen, and President of the European Council, Charles Michel, represented the EU at...

SSCC promotes the Serbian ICT market to Swiss companies

SSCC promotes the Serbian ICT market to Swiss companies in cooperation with Switzerland Global Enterprise. Switzerland Global Enterprise S-GE...

The EU has greenlit a deal with the US and German firms to secure 300 million doses of their coronavirus vaccine for the bloc. Deliveries are expected to start by the end of this year.

The European Commission approved a contract with German pharmaceutical firm BioNTech and their US partner Pfizer on Wednesday, guaranteeing that the bloc with receive millions of doses of their experimental coronavirus vaccine.

After locking down the details of the deal on Tuesday, Commission President Ursula von der Leyen said the bloc hopes to “deploy it quickly, everywhere in Europe.”

Under the deal, the 27-member bloc will receive up to 300 million doses of the vaccine. German officials have said they expect to roll it out within the first three months of 2021.

The European Commission already approved three other deals with pharmaceutical companies working on COVID-19 vaccines which would allow the bloc to buy nearly one billion doses of potential vaccines to come.

EU expects doses at same time as US

Peter Liese, Coordinator of the European Parliament’s Committee on Public Health, acknowledged that negotiations with the pharmaceutical firms took longer than with other countries, but said it was necessary to ensure the best deal for the EU.

The companies “need to respect European law […] and that’s why it took a while,” he told DW. “But now the deal is done.”

Despite signing a deal only after the US and UK, Liese said the European Union won’t be in the back of the line when it comes to receiving vaccine doses.

“It will be delivered at the same time to every partner that has signed the deal,” he said, noting as well that the vaccine is being produced “mainly in Germany.”

Securing vaccine rollout in the EU

German Health Minister Jens Spahn said Tuesday the vaccine is likely to be ready in the first quarter of 2021 and hopes to secure 100 million doses for Germany.

Spahn, who contracted COVID-19 himself in late October, said it’s important that Germany and the rest of the EU don’t fall behind in the vaccine rollout.

“We of course couldn’t explain to Europeans and especially to Germans if a vaccine would be available and [distributed] in the USA or in other regions in the world, but not in Germany and Europe.”

Spahn emphasized that the European Commission had the mandate to negotiate with pharmaceutical companies — not individual states.

France, Germany, Spain and others in the 27-member bloc “absolutely” would have been able to secure national contracts, Spahn said. “The question is, whether that would have reflected our understanding of European solidarity.”

Source: Deutsche Welle

Related Articles

EU Donates Ambulances, Mobile Respirators And Protective Equipment

Twelve new ambulances with modern equipment, decontamination vehicles and protective equipment will be available to the health system in Serbia thanks to a European...

Government Passes New Anti-coronavirus Measures

The Serbian government adopted new measures to suppress the epidemic caused by the COVID-19 infectious disease, whose implementation will begin on 24 November 2020. The...

US pharma firm Moderna says its COVID-19 vaccine is 94.5% effective

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker...

Western Balkans Summit in Sofia

Important Steps Taken to Advance Regional Cooperation to Boost Socio-economic Recovery and Convergence with the EU The European Commission welcomes the commitment expressed today at...

Serbia To Join European Dialogue On Digitalisation

Prime Minister Ana Brnabic participated today as a special guest at the conference "Swiss Digital Days", which is held for the fourth time, with...

Dr Marko Savković, Executive Director, Belgrade Fund For Political Excellence

In The Wrong Street

Without progress on key chapters, 23, 24 and 35, membership negotiations could grind to a halt. Making matters even worse, as a society we’ve...

Nataša Dragojlović, Coordinator of The National Convention On The European Union

No Progress Without A Change In Approach

Both the eu and membership candidate countries need to change their approach. Candidates need to work faster and more decisively, and the eu needs...

Nikola Burazer, Centre For Contemporary Politics

Serbia Needs To Do Much Better: Democracy And Rule Of Law Are Key

The critical tones of the european commission report make it unlikely that Serbia’s EU accession process will speed up substantially, though that represents a...